Nitric oxide and the immune response

被引:2669
作者
Bogdan, C [1 ]
机构
[1] Univ Erlangen Nurnberg, Inst Clin Microbiol Immunol & Hyg, D-91054 Erlangen, Germany
关键词
D O I
10.1038/ni1001-907
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During the past two decades, nitric oxide (NO) has been recognized as one of the most versatile players in the immune system. It is involved in the pathogenesis and control of infectious diseases, tumors, autoimmune processes and chronic degenerative diseases. Because of its variety of reaction partners (DNA, proteins, low-molecular weight thiols, prosthetic groups, reactive oxygen intermediates), its widespread production (by three different NO synthases (NOS) and the fact that its activity is strongly influenced by its concentration, NO continues to surprise and perplex immunologists. Today, there is no simple, uniform picture of the function of NO in the immune system. Protective and toxic effects of NO are frequently seen in parallel. Its striking inter- and intracellular signaling capacity makes it extremely difficult to predict the effect of NOS inhibitors and NO donors, which still hampers therapeutic applications.
引用
收藏
页码:907 / 916
页数:10
相关论文
共 192 条
  • [1] Rote of inducible nitric oxide synthase in resistance to Mycobacterium leprae in mice
    Adams, LB
    Job, CK
    Krahenbuhl, JL
    [J]. INFECTION AND IMMUNITY, 2000, 68 (09) : 5462 - 5465
  • [2] Immunologic NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41
    Adamson, DC
    Wildemann, B
    Sasaki, M
    Glass, JD
    McArthur, JC
    Christov, VI
    Dawson, TM
    Dawson, VL
    [J]. SCIENCE, 1996, 274 (5294) : 1917 - 1921
  • [3] Thymic dendritic cells express inducible nitric oxide synthase and generate nitric oxide in response to self- and alloantigens
    Aiello, S
    Noris, M
    Piccinini, G
    Tomasoni, S
    Casiraghi, F
    Bonazzola, S
    Mister, M
    Sayegh, MH
    Remuzzi, G
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (09) : 4649 - 4658
  • [4] Viral mutation accelerated by nitric oxide production during infection in vivo
    Akaike, T
    Fujii, S
    Kato, A
    Yoshitake, J
    Miyamoto, Y
    Sawa, T
    Okamoto, S
    Suga, M
    Asakawa, M
    Nagai, Y
    Maeda, H
    [J]. FASEB JOURNAL, 2000, 14 (10) : 1447 - 1454
  • [5] Allione A, 1999, J IMMUNOL, V163, P4182
  • [6] Andonegui G, 1999, J IMMUNOL, V162, P2922
  • [7] Angulo I, 2000, BLOOD, V95, P212
  • [8] Granulocytic ehrlichiosis in mice deficient in phagocyte oxidase or inducible nitric oxide synthase
    Banerjee, R
    Anguita, J
    Fikrig, E
    [J]. INFECTION AND IMMUNITY, 2000, 68 (07) : 4361 - 4362
  • [9] Banick PD, 1997, J CELL PHYSIOL, V172, P12, DOI 10.1002/(SICI)1097-4652(199707)172:1<12::AID-JCP2>3.0.CO
  • [10] 2-G